Chemical industry under constant stress

The main reason to this was the significant decline in medical production after companies applied pull-forward impacts in 2025 due to the risk of US tariffs. Chemical production, on the other hand, increased slightly. However, it remained below the previous year's level. At 75.1%, capacity utilization remained unprofitable. Job cuts continued.

A Sustainable Recovery is Not in Sight

High energy, raw material, and transportation costs are weighing on the sector as a result of the conflict in the Middle East. The closure of the Strait of Hormuz is exacerbating supply chain problems and driving up oil, gaseous and naphtha prices. In parts of the chemical business, demand temporarily picks up due to precautionary orders. The German Chemical sector Association (VCI) Managing Director Wolfgang Große Entrup said, "The Middle East conflict is cutting a deep swathe through the global economy. We are not seeing a mood of optimism, however are instead experiencing geopolitical hoarding, which is giving our sector a brief respite, not a direction reversal. This is a panicked interim peak from which parts of the chemical sector are also benefiting in the short term. We firmly believe that the hardest part is still ahead of us."

However, the VCI does not expect a sustainable recovery this year. Once the situation in the Strait of Hormuz returns to healthy, competitive pressure will increase again. VCI Managing Director Wolfgang Große Entrup commented, "The chemical sector is struggling, pharma is preparing to even greater challenges. A few stable figures are not a turnaround. The plain truth is that the chemical sector is still under constant stress - burdened by untamed bureaucracy, high costs and global turbulence. Germany will continue to lose competitiveness if Berlin and Brussels do not take countermeasures. We have little affect on geopolitical crises - however we do have affect on the conditions in which we operate. The policy of small steps is no longer enough. Strong leadership, reliability and a clear manufacturing policy course are now crucial. This also applies to China. The massive increase in capacity and state-subsidized production are putting Europe's sector under rising pressure and hitting many sectors hard. However, it is also clear that thorough isolation and new trade barriers are not a good solution. What is crucial is that the existing trade protection instruments must first be applied efficiently - this is the only way to help rapidly. Europe needs a self-confident and fair approach to China - with instruments that efficiently limit distortions of competition without jeopardizing international value chains."

The figures at a glance

In view of the geopolitical risks, a reliable forecast is currently only possible to a limited extent. The VCI still expects 2026 to be a difficult year: production is likely to fall again to the year as a whole. while rising prices could support sales, margins will remain under pressure.

Seasonally adjusted, chemical-medical production fell by 2.8% in the first quarter of 2026 compared to the previous quarter and was almost 6% down on the previous year. Pharmaceuticals significantly dampened earnings, while chemicals grew slightly. Capacity utilization rose slightly to 75.1% - however remains below a profitable level.

The downward direction in producer prices was halted: compared to the previous quarter, there was a slight increase of 0.2%. Compared to the previous year, however, prices were still around 1% reduce. At the same time, cost pressure intensified significantly: prices to crude oil and crude oil-related items in particular rose sharply.

Seasonally adjusted sales rose by 2.1% to €50.9 billion. However, it was 5.4% below the previous year's figure. Additional orders at the beginning of the year partly indicate precautionary orders and stockpiling in view of the escalation in the Persian Gulf.

VCI - German Chemical sector Association

Company contact

ADCs to Precision Cancer Therapy

Circular Plastics Economy

Siemens Joins the Global Impact Coalition

Upcoming Virtual Events

Capillary Electrophoresis in Biotherapeutic research: Platform Methods, Fragment Workflows, and ADC Characterization

Safer, Scalable medical Manufacturing with Flow Chemistry

thorough Insights into Antibody–Drug Conjugates (ADC) to Precision Cancer Therapy

Operationalizing AI in Polymer research: How Syensqo Is Scaling Impact with the Citrine Platform

Orion Announced Plans to Shut Down Carbon Black vegetation

Dow to Shut Down Three Upstream European Assets

Jens Birgersson Becomes New Brenntag CEO

Merck Acquires Chromatography Business from JSR Life Sciences

Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring

Newsletter & e-edition